(NASDAQ:AMGN) Research and Development Infrastructure Investment Expected to Create Hundreds of U.S. Jobs THOUSAND OAKS, Calif., Sept. 2, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its...
Related Questions
How will the $600 million R&D investment affect Amgen’s earnings guidance and valuation multiples?
What competitive advantage does this new science and innovation center give Amgen relative to peers such as Johnson & Johnson, Pfizer, and GSK?
When is the projected job creation timeline and how might the added headcount impact Amgen’s operating expenses and R&D productivity over the next few years?